Related parties

The Company has a long-term pharmaceutical distribution agreement with AmerisourceBergen pursuant to which the Company sources branded and generic pharmaceutical products from AmerisourceBergen principally for its U.S. operations. Additionally, AmerisourceBergen receives sourcing services for generic pharmaceutical products.

Related party transactions with AmerisourceBergen (in millions):



	Three months ended May 31,				Nine months ended May 31,
	2019		2018		2019		2018
Purchases, net	$	14,684	$	15,830	$	43,070	$	39,566



	May 31, 2019		August 31, 2018
Trade accounts payable, net	$	6,520	$	6,274